Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune Addison's disease. Current knowledge and prospects]

A De Bellis, A Bizzarro, F Fiordelisi

    Minerva Endocrinologica
    |March 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Unlocking personalized endometrial cancer treatment: the critical role of the BBIRE biobank in sample collection and distribution.

    Frontiers in molecular biosciences·2026
    Same author

    Transit time flow measurement in off-pump surgery: is it a functional index of the biological graft integrity?

    European review for medical and pharmacological sciences·2024
    Same author

    Dramatic response to regorafenib in early glioblastoma progression: case report and review of the literature.

    European review for medical and pharmacological sciences·2022
    Same author

    An intensive task-oriented circuit training positively impacts gait biomechanics in MS patients.

    NeuroRehabilitation·2020
    Same author

    Endocrine rhythms and sport: it is time to take time into account.

    Journal of endocrinological investigation·2019
    Same author

    Evaluation of genotyping methods and costs for MTHFR, CBS and MTRR polymorphisms in patients with vitiligo.

    European review for medical and pharmacological sciences·2019

    Idiopathic Addison's disease (IAD) is an autoimmune disorder often linked to genetic factors and adrenal autoantibodies (AA). High AA titers suggest disease progression, while lower titers may indicate remission or reversal with corticosteroid therapy.

    Area of Science:

    • Endocrinology
    • Immunology
    • Genetics

    Context:

    • Idiopathic Addison's disease (IAD) is a chronic autoimmune endocrine disorder.
    • It affects 50-100 individuals per million, with an incidence of 5-6 cases per million annually.
    • Genetic predispositions, including specific HLA phenotypes, are associated with IAD.

    Purpose:

    • To investigate the role of adrenal autoantibodies (AA) in the pathogenesis and progression of Idiopathic Addison's disease (IAD).
    • To explore the correlation between AA titers, clinical manifestations, and potential therapeutic interventions.

    Summary:

    • Adrenal autoantibodies (AA) are implicated in IAD pathogenesis, potentially via cytotoxic mechanisms targeting adrenal cells or P450c enzymes like P450c21.
    • Subclinical adrenocortical impairment, marked by AA presence, can precede overt IAD symptoms.

    Related Experiment Videos

  • High AA titers (≥1:8) correlate with likely disease progression, while spontaneous remission or corticosteroid-induced reversal of AA titers can occur, particularly in earlier disease stages.

    • Impact:

    • Understanding the immunological markers and progression patterns of IAD can aid in early diagnosis and risk stratification.
    • Identifying potential therapeutic strategies, such as corticosteroid therapy, for managing subclinical or advanced stages of IAD.
    • Highlights the pathogenic role and diagnostic significance of adrenal autoantibodies in autoimmune adrenal insufficiency.